{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:16:34Z","timestamp":1788383794488,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.soc.2026.03.001","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:35:29Z","timestamp":1783539329000},"page":"785-800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of Extracranial Germ Cell Tumors in Pediatric Patients"],"prefix":"10.1016","volume":"35","author":[{"given":"Brent R.","family":"Weil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatim","family":"Thaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan J.","family":"Dicken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barrie S.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.soc.2026.03.001_bib1","series-title":"Cancer incidence and survival among children and adolescents: united States SEER program 1975-1995","year":"1999"},{"issue":"4","key":"10.1016\/j.soc.2026.03.001_bib2","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1470-2045(15)00545-8","article-title":"Paediatric extracranial germ-cell tumours","volume":"17","author":"Shaikh","year":"2016","journal-title":"Lancet Oncol"},{"issue":"20","key":"10.1016\/j.soc.2026.03.001_bib3","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1002\/cncr.25454","article-title":"Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006","volume":"116","author":"Poynter","year":"2010","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.soc.2026.03.001_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35706","article-title":"Racial\/ethnic differences in trends of testicular germ cell tumor incidence in the United States, 1992-2021","volume":"131","author":"Almeida","year":"2025","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.soc.2026.03.001_bib5","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0022-5347(01)64838-9","article-title":"Association of Down\u2019s syndrome and testicular cancer","volume":"157","author":"Dieckmann","year":"1997","journal-title":"J Urol"},{"issue":"9","key":"10.1016\/j.soc.2026.03.001_bib6","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jpedsurg.2016.03.006","article-title":"Tumor risk of children with 45,X\/46,XY gonadal dysgenesis in relation to their clinical presentations: further insights into the gonadal management","volume":"51","author":"Tam","year":"2016","journal-title":"J Pediatr Surg"},{"issue":"4","key":"10.1016\/j.soc.2026.03.001_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26913","article-title":"Gonadal dysgenesis is associated with worse outcomes in patients with ovarian nondysgerminomatous tumors: a report of the Children\u2019s Oncology Group AGCT 0132 study","volume":"65","author":"Dicken","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.soc.2026.03.001_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/bjc.2017.358","article-title":"Family history of cancer in children and adolescents with germ cell tumours: a report from the Children\u2019s Oncology Group","volume":"118","author":"Poynter","year":"2018","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.soc.2026.03.001_bib9","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/jamaoncol.2018.6477","article-title":"Association of inherited pathogenic variants in checkpoint Kinase 2 (CHEK2) with susceptibility to testicular germ cell tumors","volume":"5","author":"AlDubayan","year":"2019","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.soc.2026.03.001_bib10","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.juro.2007.11.080","article-title":"A 5-Year followup study of asymptomatic men with testicular microlithiasis","volume":"179","author":"DeCastro","year":"2008","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.soc.2026.03.001_bib11","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1038\/s41467-023-38378-9","article-title":"Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence","volume":"14","author":"Xu","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.soc.2026.03.001_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.clp.2020.11.010","article-title":"Neonatal malignant disorders: germ cell tumors","volume":"48","author":"Shah","year":"2021","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.soc.2026.03.001_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9059382","article-title":"Pediatric germ cell tumors: a developmental perspective","volume":"2018","author":"Pierce","year":"2018","journal-title":"Adv Urol"},{"issue":"2","key":"10.1016\/j.soc.2026.03.001_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1200\/JCO.2014.58.3369","article-title":"Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States","volume":"33","author":"Frazier","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.soc.2026.03.001_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.soc.2020.11.011","article-title":"Management of germ cell tumors in pediatric patients","volume":"30","author":"Weil","year":"2021","journal-title":"Surg Oncol Clin N Am"},{"issue":"2","key":"10.1016\/j.soc.2026.03.001_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/cncr.29732","article-title":"Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the malignant germ cell tumor International Collaborative","volume":"122","author":"Pashankar","year":"2016","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.soc.2026.03.001_bib17","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.3390\/cancers15174302","article-title":"Role of alpha-fetoprotein (AFP) in diagnosing childhood cancers and genetic-related chronic diseases","volume":"15","author":"G\u0142owska-Ciemny","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.soc.2026.03.001_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1203\/00006450-198101000-00012","article-title":"Serum alpha fetoprotein (AFP) levels in normal infants","volume":"15","author":"Wu","year":"1981","journal-title":"Pediatr Res"},{"issue":"20","key":"10.1016\/j.soc.2026.03.001_bib19","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1002\/cncr.32363","article-title":"\u03b1-Fetoprotein as a predictor of outcome for children with germ cell tumors: a report from the malignant germ cell international consortium","volume":"125","author":"O\u2019Neill","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2026.03.001_bib20","article-title":"Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance","volume":"1","author":"Montgomery","year":"2011","journal-title":"Open Access J Urol"},{"issue":"5","key":"10.1016\/j.soc.2026.03.001_bib21","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.3390\/ijms22052654","article-title":"Liquid biopsies in the clinical management of germ cell tumor patients: state-of-the-art and future directions","volume":"22","author":"Lobo","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"20","key":"10.1016\/j.soc.2026.03.001_bib22","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.2009.26.4481","article-title":"American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors","volume":"28","author":"Gilligan","year":"2010","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.soc.2026.03.001_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.clinbiochem.2004.05.008","article-title":"Human chorionic gonadotropin in cancer","volume":"37","author":"Stenman","year":"2004","journal-title":"Clin Biochem"},{"issue":"2","key":"10.1016\/j.soc.2026.03.001_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eururo.2016.07.029","article-title":"Serum levels of MicroRNA miR-371a-3p: a sensitive and specific new biomarker for germ cell tumours","volume":"71","author":"Dieckmann","year":"2017","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.soc.2026.03.001_bib25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2019.10.005","article-title":"Serum MicroRNA-371a-3p levels predict viable germ cell tumor in chemotherapy-na\u00efve patients undergoing retroperitoneal lymph node dissection","volume":"77","author":"Lafin","year":"2020","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.soc.2026.03.001_bib26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ucl.2019.04.002","article-title":"Management of stage II germ cell tumors","volume":"46","author":"Ghandour","year":"2019","journal-title":"Urol Clin North Am"},{"issue":"1","key":"10.1016\/j.soc.2026.03.001_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.48083\/RZEQ2256","article-title":"The past and future of biomarkers in testicular germ cell tumors","volume":"1","author":"Bagrodia","year":"2020","journal-title":"Soci\u00e9t\u00e9 Int D\u2019Urologie J"},{"issue":"1","key":"10.1016\/j.soc.2026.03.001_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/jpsu.2001.19993","article-title":"The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a pediatric intergroup trial (POG 9049\/CCG 8882)","volume":"36","author":"Rescorla","year":"2001","journal-title":"J Pediatr Surg"},{"issue":"14","key":"10.1016\/j.soc.2026.03.001_bib29","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1200\/JCO.20.03296","article-title":"Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): results from the IGCCCG update consortium","volume":"39","author":"Gillessen","year":"2021","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.soc.2026.03.001_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-87-3-293","article-title":"Cis -Diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer","volume":"87","author":"Einhorn","year":"1977","journal-title":"Ann Intern Med"},{"issue":"17","key":"10.1016\/j.soc.2026.03.001_bib31","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1200\/JCO.2004.01.006","article-title":"Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: a pediatric Intergroup Study\u2014Pediatric Oncology Group 9048 and children\u2019s cancer Group 8891","volume":"22","author":"Rogers","year":"2004","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.soc.2026.03.001_bib32","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1200\/JCO.2004.08.015","volume":"22","author":"Cushing","year":"2004","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.soc.2026.03.001_bib33","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1200\/JCO.2000.18.22.3809","article-title":"The United Kingdom children\u2019s cancer study group\u2019s second germ cell tumor study: Carboplatin, etoposide, and Bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity","volume":"18","author":"Mann","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soc.2026.03.001_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejca.2018.03.004","article-title":"Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: a report of the Malignant Germ Cell International Consortium","volume":"98","author":"Frazier","year":"2018","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.soc.2026.03.001_bib35","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jpedsurg.2015.03.026","article-title":"Surveillance after initial surgery for stage I pediatric and adolescent boys with malignant testicular germ cell tumors: report from the Children\u2019s Oncology Group","volume":"50","author":"Rescorla","year":"2015","journal-title":"J Pediatr Surg"},{"issue":"5","key":"10.1016\/j.soc.2026.03.001_bib36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1200\/JCO.2013.51.1006","article-title":"Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children\u2019s Oncology Group","volume":"32","author":"Billmire","year":"2014","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.soc.2026.03.001_bib37","first-page":"624","article-title":"Immature teratoma of the ovary","volume":"68","author":"Gershenson","year":"1986","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.soc.2026.03.001_bib38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/cncr.29732","article-title":"Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the M alignant G erm C ell Tumor International Collaborative","volume":"122","author":"Pashankar","year":"2016","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.soc.2026.03.001_bib39","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.1999.17.7.2137","article-title":"Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: a Pediatric Oncology Group\/Children\u2019s Cancer Group Intergroup Study","volume":"17","author":"Marina","year":"1999","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.soc.2026.03.001_bib40","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1200\/JCO.2016.69.5395","article-title":"High-dose chemotherapy and autologous peripheral-blood stem-cell transplantation for relapsed metastatic germ cell tumors: the Indiana university experience","volume":"35","author":"Adra","year":"2017","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.soc.2026.03.001_bib41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jpag.2020.11.014","article-title":"Imaging appearance of Nongerminoma Pediatric Ovarian Germ Cell Tumors does not discriminate benign from malignant histology","volume":"34","author":"Billmire","year":"2021","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"4","key":"10.1016\/j.soc.2026.03.001_bib42","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jpag.2022.01.009","article-title":"Multi-institutional review of the preoperative diagnostic accuracy for pediatric ovarian mature cystic teratomas","volume":"35","author":"Knaus","year":"2022","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"3","key":"10.1016\/j.soc.2026.03.001_bib43","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2022.06.013","article-title":"Utility of frozen section in pediatric and adolescent malignant ovarian nonseminomatous germ cell tumors: a report from the children\u2019s oncology group","volume":"166","author":"Dicken","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"22","key":"10.1016\/j.soc.2026.03.001_bib44","first-page":"00295-9","article-title":"Use and accuracy of intraoperative frozen section analysis for ovarian masses in children and adolescents","volume":"S1083-3188","author":"Gil","year":"2022","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"10","key":"10.1016\/j.soc.2026.03.001_bib45","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.jpedsurg.2019.10.059","article-title":"Ovarian tumors in children: how common are lesion recurrence and metachronous disease? A UK CCLG Surgeons Cancer Group nationwide study","volume":"55","author":"Braungart","year":"2020","journal-title":"J Pediatr Surg"},{"issue":"3 Pt 2","key":"10.1016\/j.soc.2026.03.001_bib46","first-page":"981","article-title":"A review of scrotal violation in testicular cancer: is adjuvant local therapy necessary?","volume":"153","author":"Capelouto","year":"1995","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.soc.2026.03.001_bib47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.ju.0000101185.90327.b4","article-title":"Experience with testis sparing surgery for testicular teratoma","volume":"171","author":"Shukla","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.soc.2026.03.001_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/6783147","article-title":"The use of modified templates in early and advanced stage nonseminomatous germ cell tumor","volume":"2018","author":"Masterson","year":"2018","journal-title":"Adv Urol"},{"key":"10.1016\/j.soc.2026.03.001_bib49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpeds.2018.02.031","article-title":"Long-term outcome of sacrococcygeal teratoma: a controlled cohort study of urinary tract and bowel dysfunction and predictors of poor outcome","volume":"198","author":"Hambraeus","year":"2018","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.soc.2026.03.001_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.sempedsurg.2011.10.005","article-title":"Pediatric germ cell tumors","volume":"21","author":"Rescorla","year":"2012","journal-title":"Semin Pediatr Surg"},{"issue":"7","key":"10.1016\/j.soc.2026.03.001_bib51","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.2001.19.7.1943","article-title":"Multimodal treatment of malignant sacrococcygeal germ cell tumors: a prospective analysis of 66 patients of the German cooperative protocols MAKEI 83\/86 and 89","volume":"19","author":"G\u00f6bel","year":"2001","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.soc.2026.03.001_bib52","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1200\/JCO.2000.18.4.832","article-title":"Primary mediastinal germ cell tumors in children and adolescents: results of the German cooperative protocols MAKEI 83\/86, 89, and 96","volume":"18","author":"Schneider","year":"2000","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.soc.2026.03.001_bib53","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0039-6060(05)80360-5","article-title":"Prospective evaluation by computed tomography and pulmonary function tests of children with mediastinal masses","volume":"118","author":"Shamberger","year":"1995","journal-title":"Surgery"},{"issue":"7","key":"10.1016\/j.soc.2026.03.001_bib54","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3109\/01443615.2015.1004525","article-title":"Vaginal teratoma: a case report and review of the literature","volume":"35","author":"Vural","year":"2015","journal-title":"J Obstet Gynaecol"},{"issue":"9","key":"10.1016\/j.soc.2026.03.001_bib55","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/s41416-022-02000-4","article-title":"Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium","volume":"127","author":"Fonseca","year":"2022","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.soc.2026.03.001_bib56","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/cncr.29213","article-title":"Phase 2 trial of the cyclin-dependent kinase 4\/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors","volume":"121","author":"Vaughn","year":"2015","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.soc.2026.03.001_bib57","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1093\/annonc\/mdr026","article-title":"Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group\/German Testicular Cancer Study Group cooperative study","volume":"22","author":"Oechsle","year":"2011","journal-title":"Ann Oncol"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320726000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320726000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:24:17Z","timestamp":1788380657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320726000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1055320726000232"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2026.03.001","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Extracranial Germ Cell Tumors in Pediatric Patients","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2026.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}